---
category: news
title: "KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time"
excerpt: "Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes."
publishedDateTime: 2021-06-28T06:00:00Z
originalUrl: "https://www.morningstar.com/news/globe-newswire/8271199/kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time"
webUrl: "https://www.morningstar.com/news/globe-newswire/8271199/kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Morningstar, Inc.
  domain: morningstar.com

topics:
  - AI in Healthcare
  - AI

secured: "1P7Rp1yjUt3rAomR2r8kRSxzTg4m7cSAvs9DvNSzz6rUE1Ehbd+p467/pEoKsruTq8HvhKjVgDpc/zn3uHQkGiPSAEE4REJtfQ95w9YcG1cW7nBAkjWXZI1mcPdpxnd/8V0QVhYd0ZBmhFKfu/PG6N/8uxRSrogOfbgHoFMrQYK9KmRGp3hTgd9L4K0O+O/b+ORR9QLfVN1ZT4tRDXQuZvL6PioODlNSMoIMQHjcuDmtVTI4oIUrxL9JiYWsDInDzgrw+dv4z8MatHua5du9bvefvkx/79gESKfe2IZMzyCwx1BLaGTFDqSsRNJ/HReupFlbpr59bCZQJVLt4U+mLgqZ3XADkJrLf9s/RnDTSM0=;F4MUv7bRl2UDwYyGgUR1Aw=="
---

